This is a routine CEO appointment with no material financial implications. Monitor for any strategic shifts under the new CEO, but no immediate trading catalyst is present.
Price Chart
Executive Summary
Phibro Animal Health appointed Daniel (Dani) Bendheim as CEO and President effective July 1, 2026, with an employment agreement including a base salary of $850,000, target bonus of 50% of base, and a grant of 300,000 performance-based RSUs vesting based on stock price targets ($70–$100+ by June 30, 2031). This is a routine leadership transition with standard compensation terms and no financial data or red flags.
Key Facts
- Daniel Bendheim appointed CEO and President effective July 1, 2026
- Base salary of $850,000 per year with target bonus of 50% of base salary
- Initial grant of 300,000 performance-based RSUs vesting based on 90-day average stock price from $70 to $100+ by June 30, 2031
- Annual time-vesting RSU target value of approximately 50% of base salary
- Change-in-control provisions allow accelerated vesting under certain conditions
Financial Impact
No immediate financial impact; the 300,000 RSU grant is performance-based and long-dated, representing potential dilution of approximately 0.7% of current shares outstanding (based on market cap of $1.3B and stock price context).
Risk Factors
- None from this filing; the appointment appears planned and uncontroversial
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-078323 |
| Document: 0001104659-26-078323-index-headers.html | 0001104659-26-078323 |
| Document: 0001104659-26-078323-index.html | 0001104659-26-078323 |
| Document: 0001104659-26-078323.txt | 0001104659-26-078323 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 28, 2026 9w ago | 8-K | $36.95 $36.09 | ▼ −2.33% | ▼ −7.35% | $37.46 (+1.37%) |
Jun 26, 2026 13w ago | 8-K | $31.81 $34.04 | ▲ +6.99% | ▲ +7.27% | $37.46 (+17.75%) |
May 6, 2026 21w ago | 8-K | $43.16 $31.79 | ▼ −26.34% | ▼ −29.48% | $37.46 (−13.22%) |
May 5, 2026 21w ago | 8-K | $58.50 $31.79 | ▼ −45.66% | ▼ −48.44% | $37.46 (−35.97%) |
Apr 30, 2026 22w ago | 8-K | $54.66 $29.74 | ▼ −45.58% | ▼ −50.85% | $37.46 (−31.48%) |
Apr 27, 2026 22w ago | 8-K | $54.29 $33.68 | ▲ +37.96% | ▲ +43.43% | $37.46 (+31.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access